CELUTIONS
ActiveSummary
CELUTIONS has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,550 and a net result of €43,788. Equity is growing by about 31% per year across the filed financial years. Its solvency ranks better than 17% of 3,321 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
15-04
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
29-04
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
30-09
Financial
Equity above €200,000equity €209,630 ▲18.5%
A profit in every financial year since 2020 builds equity to €209,630.
19-03
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
30-09
Financial
Highest result from 2020 to 2025net €50,188 ▲46.4%
Operating result €66,585, net result €50,188, both a record.
30-09
Financial
Liquidity more than doubledcurrent ratio 7.80
Current ratio from 3.79 to 7.80; short-term debt falls from €40,299 to €23,872.
30-09
Financial
Equity above €150,000equity €176,859 ▲39.6%
A profit in every financial year since 2020 builds equity to €176,859.
06-04
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
30-09
Financial
Equity above €100,000equity €126,671 ▲37.1%
A profit in every financial year since 2020 builds equity to €126,671.
26-04
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
30-09
Financial
Weakest financial yearnet €28,568 ▼36.9%
Net result drops to €28,568, the lowest in the series; recovery starts the following year.
27-04
NBB filing
Annual accounts filed
financial year 2020 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.